SUT BEZI SARATONI: EPIDEMIOLOGIYA, MOLEKULYAR XUSUSIYATLAR VA GENETIK ASOSLAR
Main Article Content
Аннотация:
Sut bezi saratoni global miqyosda ayollar orasida eng ko‘p uchraydigan onkologik kasalliklardan biri bo‘lib, uning rivojlanishi epidemiologik, biologik va genetik omillarning murakkab o‘zaro ta’siri bilan tavsiflanadi. Ushbu tezisda sut bezi saratonining global va mintaqaviy epidemiologiyasi, yoshga bog‘liq xususiyatlari, molekulyar subtiplari hamda irsiy moyillik bilan bog‘liq asosiy genetik omillar tahlil qilindi. Xususan, BRCA1 va BRCA2 genlaridagi patogen variantlarning kasallik patogenezidagi o‘rni, klinik ahamiyati va davolash strategiyalarini tanlashdagi roli yoritildi. Shuningdek, keyingi avlod sekvenslash (NGS) texnologiyalarining aniqlik tibbiyotidagi ahamiyati, sut bezi saratonini tashxislash, prognozlash va individual davolash yondashuvlarini shakllantirishdagi imkoniyatlari muhokama qilindi. Ushbu sharh natijalari populyatsion genomika va molekulyar diagnostikani klinik amaliyotga keng joriy etish sut bezi saratoni bilan bog‘liq kasallanish va o‘lim ko‘rsatkichlarini kamaytirishga xizmat qilishi mumkinligini ko‘rsatadi.
Article Details
Как цитировать:
Библиографические ссылки:
Nikolov I, Kostev K, Kalder M. Incidence of other cancer diagnoses in women with breast cancer. Breast Cancer Res Treat. 2022;195(1):75–82.
DeSantis CE, Ma J, Gaudet MM, et al. Breast cancer statistics, 2019. CA Cancer J Clin. 2019;69(6):438–451.
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018. CA Cancer J Clin. 2018;68(6):394–424.
Heer E, Harper A, Escandor N, et al. Global burden and trends in breast cancer. Lancet Glob Health. 2020;8(8):e1027–e1037.
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020. CA Cancer J Clin. 2021;71:209–249.
Breast Cancer Facts and Statistics. 2023.
European Cancer Information System. Breast Cancer Burden in EU-27. 2020.
Lin CH, Yap YS, Lee KH, et al. Contrasting epidemiology of breast cancer. JNCI. 2019;111(12):1298–1306.
Joko-Fru WY, et al. Breast cancer in sub-Saharan Africa. Int J Cancer. 2020;147(8):2131–2141.
Tillyashaykhov MN, et al. Cancer incidence in Uzbekistan. 2021.
Sung H, et al. Cancer statistics Uzbekistan. CA Cancer J Clin. 2021;71(3):209–249.
Patel B. Review of breast cancer. Int J Pharm Sci Res. 2019;10:519–527.
Beňačka R, et al. Markers in breast cancer classification. Cancers. 2022;14(21):5444.
Han SA, Kim SW. BRCA and breast cancer. Transl Res Breast Cancer. 2021.
Petrucelli N, Daly MB, Pal T. BRCA-associated hereditary breast cancer. 2022.
Subhan MA, Parveen F, Shah H, et al. Precision medicine in breast cancer. Cancers. 2023;15(8):2204.
Qin D. Next-generation sequencing and its clinical application. Cancer Biol Med. 2019.
